Application 021742
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 2.5MG BASE | Yes | No |
| 003 | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 5MG BASE | Yes | No |
| 004 | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 10MG BASE | Yes | No |
| 005 | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 20MG BASE | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0456-1402 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1402 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1402 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1402 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1402 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1402 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1405 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1405 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1405 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1405 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1405 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1405 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1410 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1410 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1410 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1410 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1410 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1410 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1420 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1420 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1420 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1420 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1420 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 0456-1420 | Bystolic | nebivolol hydrochloride | Allergan, Inc. | NDA | Current |
| 50090-1127 | Bystolic | nebivolol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-1127 | Bystolic | nebivolol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-1307 | Bystolic | nebivolol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-1307 | Bystolic | nebivolol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-1307 | Bystolic | nebivolol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-1307 | Bystolic | nebivolol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-3326 | Bystolic | nebivolol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-3326 | Bystolic | nebivolol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-3326 | Bystolic | nebivolol hydrochloride | A-S Medication Solutions | NDA | Current |
| 55154-4621 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4621 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4621 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4621 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4621 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4621 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4622 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4622 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4622 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4622 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4622 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4622 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4623 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4623 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4623 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4623 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4623 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 55154-4623 | Bystolic | nebivolol hydrochloride | Cardinal Health | NDA | Current |
| 68151-5135 | Bystolic | nebivolol hydrochloride | Carilion Materials Management | NDA | Current |